1 hasil untuk "David Y Lin"
Menampilkan 1–1 · 2,70 detik · RSS
-
Artikel Jurnal Teks lengkap
Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib
Bruton’s tyrosine kinase (BTK) is the target of the therapeutic agent, Ibrutinib, that treats chronic lymphocyte leukemia (CLL), mantle cell lymphoma (MCL) and other B cell malignancies. Ibrutinib is a first in class, covalent BTK inhibitor that limits B-cell survival and proliferation. Designing…